About: A genome-wide association study of overall survival in pancreatic cancer patients treated with gemcitabine in CALGB 80303

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: A genome-wide association study of overall survival in pancreatic cancer patients treated with gemcitabine in CALGB 80303 Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific journal article

Attributes	Values
rdf:type	Item
description	artículu científicu espublizáu en 2012 (ast) article scientifique publié en 2012 (fr) 2012 թուականի Յունուարին հրատարակուած գիտական յօդուած (hyw) 2012 թվականի հունվարին հրատարակված գիտական հոդված (hy) наукова стаття, опублікована в січні 2012 (uk) wetenschappelijk artikel (gepubliceerd op 2012/01/15) (nl) مقالة علمية (نشرت في 15-1-2012) (ar) im Januar 2012 veröffentlichter wissenschaftlicher Artikel (de) scientific journal article (en)
publication date	wds:Q28943270-A3F30183-5156-4389-B230-A0867E4A738C
publication date	2012-01-15 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q28943270-C46A82D6-302A-402A-867B-081CCC11ABB6
language of work or name	English
cites work	wds:Q28943270-0007559A-F23B-4313-A8CA-C0ABA9624FCD wds:Q28943270-064C7434-057C-44BB-B0D4-285FCE2F3B74 wds:Q28943270-1771C60F-A59B-46F9-8246-6BA14606C1DF wds:Q28943270-177F7797-7E9C-4213-AEDB-2ECDB11C0868 wds:Q28943270-17C44743-E062-433F-AFF2-122A45410719 wds:Q28943270-31B46970-53C5-43F1-905C-CC3FC39A0CD8 wds:Q28943270-388F1AC6-8CF7-45E4-A969-ED0B4E93457E wds:Q28943270-45F604F4-2EC8-46B8-8F87-2BF679661199 wds:Q28943270-49642204-1DC2-449F-A0FE-975271766F78 wds:Q28943270-6EFD0432-12B4-43DB-8BB9-B37ABFBD109D wds:Q28943270-72CCA684-EA94-47AF-A937-8F3465CD6933 wds:Q28943270-810566B9-BB8D-4D1D-88BD-AE3056B0C2D1 wds:Q28943270-98918321-3EF0-4290-93D9-42582D1B201C wds:Q28943270-9AF1ECF4-C1A2-47DD-AA88-BCFAD74EFE49 wds:Q28943270-9FECAEB3-DB65-44A7-8514-96A2132871B6 wds:Q28943270-A2285276-D508-4A7E-B4B5-6179625C3038 wds:Q28943270-A41C695D-1EE6-43EA-B2A6-F9686CAEDAE3 wds:Q28943270-B4499545-2C3B-4E5C-A029-2FEE070CE769 wds:Q28943270-B7BDF7DC-9F7C-43DB-BF1A-3FD3D5CDFB24 wds:Q28943270-BE14D861-B8D0-47B3-A611-A66BCB8B0D7E wds:Q28943270-C40052EF-FB57-4ED5-A824-B9BF2E616984 wds:Q28943270-C78360C7-3A52-4702-B7FA-FF6B9BC3F2F0 wds:Q28943270-D0583077-CC51-4463-B262-3B78F478A9C5 wds:Q28943270-D23140C8-05FC-446C-A882-AD3FF3DCA2D1 wds:Q28943270-D9F7995C-129B-4A23-80D0-E74C98088709 wds:Q28943270-DC1F9491-6B06-4803-B278-CE219B31BFD6 wds:Q28943270-DF35F256-3B8F-43EF-A0CD-F321346E7A4F wds:Q28943270-E9DD1B4F-1F4E-4E17-945B-39F2E1DB968F wds:Q28943270-F286B219-1DB5-44A4-8065-132DEEC182FC
cites work	Genome-wide linkage scan for prostate cancer susceptibility from the University of Michigan Prostate Cancer Genetics Project: suggestive evidence for linkage at 16q23. The genomic landscapes of human breast and colorectal cancers Association of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 genetic polymorphisms with outcome in a trial of paclitaxel compared with paclitaxel plus bevacizumab in advanced breast cancer: ECOG 2100. Nuclear factor-kappaB p65/relA silencing induces apoptosis and increases gemcitabine effectiveness in a subset of pancreatic cancer cells Principal components analysis corrects for stratification in genome-wide association studies Gene mapping and expression analysis of 16q loss of heterozygosity identifies WWOX and CYLD as being important in determining clinical outcome in multiple myeloma New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada APC/CTNNB1 (?-catenin) pathway alterations in human prostate cancers Cutting edge: IL-17F, a novel cytokine selectively expressed in activated T cells and monocytes, regulates angiogenesis and endothelial cell cytokine production Increased expression of the E3-ubiquitin ligase receptor subunit betaTRCP1 relates to constitutive nuclear factor-kappaB activation and chemoresistance in pancreatic carcinoma cells WWOX: its genomics, partners, and functions FASTSNP: an always up-to-date and extendable service for SNP function analysis and prioritization. Gemcitabine and arabinosylcytosin pharmacogenomics: genome-wide association and drug response biomarkers Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial SCAN: SNP and copy number annotation Gemcitabine plus bevacizumab compared with gemcitabine plus placebo in patients with advanced pancreatic cancer: phase III trial of the Cancer and Leukemia Group B (CALGB 80303). Phase III trial of bevacizumab in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer Pathways for aberrant angiogenesis in pancreatic cancer Increase in incidence of colorectal cancer among young men and women in the United States The influence of polymorphisms of interleukin-17A and interleukin-17F genes on the susceptibility to ulcerative colitis Molecular epidemiology and its current clinical use in cancer management Multiple Genetic Loci Modulate Lung Adenocarcinoma Clinical Staging Pancreatic cancer: current and future treatment strategies Japanese single nucleotide polymorphism database for 267 possible drug-related genes Disulfiram/copper complex inhibiting NFkappaB activity and potentiating cytotoxic effect of gemcitabine on colon and breast cancer cell lines. IL-17F sequence variant (His161Arg) is associated with protection against asthma and antagonizes wild-type IL-17F activity The use of genomic information to optimize cancer chemotherapy Genetic polymorphisms of molecules associated with inflammation and immune response in Japanese subjects with functional dyspepsia Interleukin-17F suppresses hepatocarcinoma cell growth via inhibition of tumor angiogenesis
author name string	wds:Q28943270-0850E1FD-C04E-4C3B-8D5B-BB903B6DE38B wds:Q28943270-297B4A91-8E42-4E89-A1D7-A97A9B8F7048 wds:Q28943270-2D4F654F-3D00-4455-9D26-87E1B97CD586 wds:Q28943270-3FFFF80C-91F2-40FF-9E4E-853608F78128 wds:Q28943270-5BD7CD47-A6E5-4257-B62C-C26A15E3DD84 wds:Q28943270-6B54E3D7-1DC1-4AE6-96FC-D17BD13B1347 wds:Q28943270-A773A894-1478-4D36-9DF9-895782F9ED4F wds:Q28943270-DF83F81C-9FA7-4F07-9F39-277C325CB345 wds:Q28943270-DFE7DFBA-F3BB-4950-B492-3869261E25F3
author name string	Liang Li Chen Jiang Kathleen M. Giacomini Kouros Owzar Donna Hollis Patrick Evans Herbert Hurwitz Richard L. Schilsky Richard M. Goldberg
rdfs:label	A genome-wide association study of overall survival in pancreatic cancer patients treated with gemcitabine in CALGB 80303 (en) A genome-wide association study of overall survival in pancreatic cancer patients treated with gemcitabine in CALGB 80303 (ast)
skos:prefLabel	A genome-wide association study of overall survival in pancreatic cancer patients treated with gemcitabine in CALGB 80303 (en) A genome-wide association study of overall survival in pancreatic cancer patients treated with gemcitabine in CALGB 80303 (ast)
name	A genome-wide association study of overall survival in pancreatic cancer patients treated with gemcitabine in CALGB 80303 (en) A genome-wide association study of overall survival in pancreatic cancer patients treated with gemcitabine in CALGB 80303 (ast)
author	wds:Q28943270-016D7390-00D8-4AE7-A3F2-ABA44747AD2A wds:Q28943270-11222D09-3E06-4E69-B6AB-7746CD9898BF wds:Q28943270-1A937892-4B4B-4195-8104-94C8779AAED6 wds:Q28943270-258C4574-9808-4DBD-8807-E1A38FE92586

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 195 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software